パーキンソン病（PD）の日本人成人患者を対象としたLu AF28996の臨床試験

基本情報

NCT ID

NCT06004180

ステータス

完了

試験のフェーズ

第1相

試験タイプ

介入

目標被験者数

6

治験依頼者名

H. Lundbeck A/S

概要

This trial will evaluate the effects of Lu AF28996 in adult Japanese men and women with Parkinson's disease (PD). The main goals of the trial are to learn more about a) the safety and tolerability of Lu AF28996 (any new or worsening medical issues the participants have with treatment), and b) the pharmacokinetic parameters of Lu AF28996 (how the drug is absorbed, distributed, and processed by the body). Participants will take Lu AF28996 capsules orally once a day (OD). The participants will start with a low dose of Lu AF28996, which will be increased gradually over a period of 2 weeks, and then decreased gradually over a period of about 2 weeks.

対象疾患

介入

依頼者（Sponsor）

実施施設 (1)